Cargando…

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19

• Chemotherapy resumption after convalescence from COVID-19 is safe and feasible. • No guidelines exist for resumption of chemotherapy in patients with COVID-19. • Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently.

Detalles Bibliográficos
Autores principales: Liontos, Michalis, Kaparelou, Maria, Karofylakis, Emmanouil, Kavatha, Dimitra, Mentis, Andreas, Zagouri, Flora, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390730/
https://www.ncbi.nlm.nih.gov/pubmed/32766415
http://dx.doi.org/10.1016/j.gore.2020.100615
_version_ 1783564501113634816
author Liontos, Michalis
Kaparelou, Maria
Karofylakis, Emmanouil
Kavatha, Dimitra
Mentis, Andreas
Zagouri, Flora
Terpos, Evangelos
Dimopoulos, Meletios-Athanasios
author_facet Liontos, Michalis
Kaparelou, Maria
Karofylakis, Emmanouil
Kavatha, Dimitra
Mentis, Andreas
Zagouri, Flora
Terpos, Evangelos
Dimopoulos, Meletios-Athanasios
author_sort Liontos, Michalis
collection PubMed
description • Chemotherapy resumption after convalescence from COVID-19 is safe and feasible. • No guidelines exist for resumption of chemotherapy in patients with COVID-19. • Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently.
format Online
Article
Text
id pubmed-7390730
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73907302020-07-30 Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19 Liontos, Michalis Kaparelou, Maria Karofylakis, Emmanouil Kavatha, Dimitra Mentis, Andreas Zagouri, Flora Terpos, Evangelos Dimopoulos, Meletios-Athanasios Gynecol Oncol Rep Case Report • Chemotherapy resumption after convalescence from COVID-19 is safe and feasible. • No guidelines exist for resumption of chemotherapy in patients with COVID-19. • Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently. Elsevier 2020-07-30 /pmc/articles/PMC7390730/ /pubmed/32766415 http://dx.doi.org/10.1016/j.gore.2020.100615 Text en © 2020 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Liontos, Michalis
Kaparelou, Maria
Karofylakis, Emmanouil
Kavatha, Dimitra
Mentis, Andreas
Zagouri, Flora
Terpos, Evangelos
Dimopoulos, Meletios-Athanasios
Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
title Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
title_full Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
title_fullStr Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
title_full_unstemmed Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
title_short Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
title_sort chemotherapy resumption in ovarian cancer patient diagnosed with covid-19
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390730/
https://www.ncbi.nlm.nih.gov/pubmed/32766415
http://dx.doi.org/10.1016/j.gore.2020.100615
work_keys_str_mv AT liontosmichalis chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19
AT kapareloumaria chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19
AT karofylakisemmanouil chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19
AT kavathadimitra chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19
AT mentisandreas chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19
AT zagouriflora chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19
AT terposevangelos chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19
AT dimopoulosmeletiosathanasios chemotherapyresumptioninovariancancerpatientdiagnosedwithcovid19